Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis
Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)J Clin Endocrinol Metab. 2016 May;101(5):2023-30
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
94 postmenopausal women with osteoporosis were randomized to receive either teriparatide, denosumab, or a combination of the two treatments. The purpose of this study was to determine the effectiveness of combined therapy with regards to bone microarchitecture and estimated strength. Findings indicated that combination therapy of teriparatide and denosumab significantly improved most volumetric bo...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE